Celon – Indian Pharmaceutical Manufacturer
Celon
Celon Laboratories Private Limited (Celon Labs) is an Indian pharmaceutical company based in Hyderabad, Telangana. It began operations in 2007. In 2020 a 74% controlling stake in Celon was acquired by the international pharmaceutical group ZNZ Pharma, which now operates as KELIX bio.
The company focuses on oncology (the Vivilon range) and critical care (the Revilon range), including cardiology and anaesthesia products. Celon makes oral and injectable medicines, including technically complex forms such as emulsions, depot formulations, liposomal and nanoparticle products — for example albumin-bound paclitaxel nanoparticles, octreotide and leuprolide depots, and bendamustine.
Manufacturing is based in Hyderabad. Its cytotoxic injectables facility has operated since 2008 and is WHO-GMP certified. Besides India, Celon supplies more than 45 countries in Latin America, the CIS, Africa and Southeast Asia.
Unifarm carries a Celon oncology medicine: Dacilon (dactinomycin).